Wikisage, the free encyclopedia of the second generation, is digital heritage
Drisapersen: Difference between revisions
Jump to navigation
Jump to search
(→Links) |
mNo edit summary |
||
Line 2: | Line 2: | ||
<ref>https://www.whocc.no/atc_ddd_index/?code=M09AX04</ref> | <ref>https://www.whocc.no/atc_ddd_index/?code=M09AX04</ref> | ||
PRO051/GSK2402968 is considered an orphan drug | PRO051/GSK2402968 is considered an orphan drug | ||
Drisapersen | |||
differs from eteplirsen in that it is an 18-mer 2′O-methyl phosphorothioate type of AO, which is negatively charged <ref>[https://www.dovepress.com/eteplirsen-in-the-treatment-of-duchenne-muscular-dystrophy-peer-reviewed-fulltext-article-DDDT Eteplirsen in the treatment of Duchenne muscular dystrophy]</ref> | |||
[[Duchenne muscular distrophy]] | [[Duchenne muscular distrophy]] | ||
==Links== | ==Links== |
Revision as of 23:38, 11 September 2019
An exon skipping experimental Medicine[1] [2] PRO051/GSK2402968 is considered an orphan drug Drisapersen differs from eteplirsen in that it is an 18-mer 2′O-methyl phosphorothioate type of AO, which is negatively charged [3] Duchenne muscular distrophy
Links
Duchenne muscular dystrophy: Still an incurable disease
Eteplirsen a 30-nucleotide phosphorodiamidate morpholino oligomer
References: |